HCPCS Code G0480: Drug Testing, Definitive, 1–7 Drug Class(es), Including Metabolites, Per Day, Excluding Immunoassays

Obtain a list of the documentation and billing requirements needed to properly use and bill for HCPCS code G0480 from our short guide.

Use Code

## **What is HCPCS code G0480?** HCPCS code G0480 is a code that has the following description: Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to GC/MS (any type, single or tandem) and LC/MS (any type, single or tandem and excluding immunoassays (e.g., IA, EIA, ELISA, EMIT, FPIA) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed. The code describes definitive drug testing performed using high-complexity methodologies such as gas chromatography/mass spectrometry (GC/MS) or liquid chromatography/mass spectrometry (LC/MS). Definitive drug testing is used to identify specific drugs and metabolites in a patient’s specimen (urine, blood, or other body fluid), either qualitatively (presence/absence) or quantitatively (concentration levels). To be more specific, G0480 applies when the laboratory analyzes 1–7 drug classes per specimen. The tests mentioned by the code are most often used in pain management, addiction medicine, psychiatry, emergency medicine, and primary care to monitor compliance, detect misuse or diversion, and inform clinical decision-making.

## **Documentation requirements** For G0480 to be considered medically necessary and reimbursed, the patient's medical record must include specific documentation. This is crucial for justifying the need for the test. Key documentation requirements include: - **A patient-specific, written order**: The order must be signed and dated by the ordering clinician. It must specify the exact drugs or drug classes to be tested as well as the methodology and the results, General "standing orders" or "custom panels" are not acceptable. - **Proof of medical necessity**: The documentation must show why the definitive test is needed for this particular patient. This can be based on: An inconsistent presumptive test result that doesn't match the patient's self-report, medical history, or prescribed medications. The need to identify a specific drug or metabolite that a presumptive test can't detect. The need for a definitive concentration of a drug to guide treatment decisions. The patient's history of substance abuse, physical examination findings, or previous lab results. - **The clinical rationale**: The documentation should explain how the test results will be used to guide the patient's treatment plan. - **Risk assessment**: For patients on chronic opioid therapy (COT), the record must contain a validated risk assessment and rationale for the frequency of testing. Do note that some carriers require prior presumptive testing unless definitive testing is directly justified.

## **Billing requirements** Billing for G0480 requires strict adherence to specific guidelines to ensure proper reimbursement. - **One code per day**: Only one definitive drug testing code (G0480-G0483 or G0659) can be billed per patient per day, regardless of the number of drug classes tested. - **Bundled services**: Specimen validity testing is considered a quality control measure and is included in the G0480 code. It cannot be billed separately. - **Frequency limits**: Medicare and many private payers have frequency limits on definitive drug testing. For example, a common guideline for patients with 31-90 days of abstinence is 1-3 tests per month. The frequency must always be medically justified and documented. - **No pass-through billing**: Only the provider who performed the service may bill for it. - **Modifier**: Some payers may require the use of a KX modifier on the claim to indicate that the service is medically necessary and meets the criteria for coverage. - **Payer policies**: Commercial payers may accept either G-codes or CPT codes—check payer policy.

## **Other relevant codes** - **G0481**: Drug test, definitive, 8–14 drug classes. - **G0482**: Drug test, definitive, 15–21 drug classes. - **G0483**: Drug test, definitive, 22+ drug classes.

Frequently asked questions

Yes, but only if medically necessary and documentation supports why definitive testing was required in addition to presumptive testing.

Presumptive testing (e.g., immunoassay) screens for drug classes but may yield false positives/negatives. Meanwhile, definitive testing (e.g., LC/MS, GC/MS) confirms the presence of specific drugs/metabolites with higher accuracy.

Per CMS, a drug class is defined based on its pharmacological category, not individual analytes.